Table 1 Healthy controls and Scleroderma patient’s data
Name | Sex | Age | Disease duration | Skin score | Endothelial cells/perivascular cells | Fibroblasts |
|---|---|---|---|---|---|---|
HC1 | F | 42 | – | + | – | |
HC2 | F | 28 | – | ++ | + | |
HC3 | F | 52 | – | + | – | |
HC4 | M | 28 | – | + | – | |
Diffuse SSc 1 | F | 62 | 2 years | 24 | ++ | + |
Diffuse SSc 2 | F | 47 | 1 year | 15 | +++ | ++ |
Diffuse SSc 3 | F | 47 | 8 years | 15 | +++ | ++ |
Diffuse SSc 4 | F | 72 | 1 year | 34 | ++ | ++ |
Diffuse SSc 5 | M | 33 | 3 years | 18 | ++ | ++ |
Diffuse SSc 6 | M | 36 | 7 years | 35 | +++ | ++ |
Diffuse SSc 7 | M | 61 | 5 years | 54 | +++ | ++ |
Limited SSc 1 | F | 42 | 2 years | 3 | +++ | ++ |
Limited SSc 2 | F | 52 | 2 years | 3 | ++ | + |
Limited SSc 3 | F | 42 | 2 years | 4 | ++ | ++ |
Limited SSc 4 | F | 68 | 1 year | 0 | + | + |
Limited SSc 5 | F | 37 | 1 year | 2 | ++ | + |
Limited SSc 6 | F | 52 | 5 years | 16 | ++ | ++ |
Limited SSc 7 | F | 44 | 2 years | 3 | +++ | + |
Biopsies used in IF | ||||||
HC 4 | F | 63 | ||||
HC 5 | M | 44 | ||||
HC 6 | F | 50 | ||||
Diffuse SSc 8 | F | 60 | 5 years | 12 | ||
Diffuse SSc 9 | M | 62 | 2 months | 23 | ||
Limited SSc 10 | F | 74 | 4 years | 0 | ||